Efficacy of an adjusted treatment strategy on the management and in-hospital outcome of patients with STEMI during the COVID-19 pandemic

• 作者: Jing Wang Inam Ullah Zhou Dong Zekang Ye Qian Gu Chuchu Tan Jiazheng Ma Jianzhen Teng Lu Shi Xiaoxuan Gong Yong Li Liang Yuan Zhihui Xu Chunjian Li
• 来源期刊: 生物医学研究杂志（英文版）
• 学科: 医学
• 年，卷（期）: 2022,（1）
• 所属期刊栏目: LETTERS TO THE EDITOR
• 页码范围: 70-72
• 页数: 3页
• 分类号: R542.2
• 语种: 英文

摘要

Dear Editor, The coronavirus disease 2019(COVID-19)broke out in early December 2019 in Wuhan,China[1],which put tremendous pressure on the medical system.A nationwide lockdown and strict quarantine measures proved effective in reducing the spread of the pandemic.However,it might have affected the management of time-dependent diseases such as ST-elevation myocardial infarction(STEMI)[2].To optimize the treatment of STEMI patients and minimize medical staff contacting COVID-19 in the epidemical regions while preventing and controlling the epidemic,Chinese cardiologists had developed a Chinese Society of Cardiology expert consensus on principles of clinical management of STEMI patients during the COVID-19 epidemic and adjusted the treatment strategy of acute myocardial infarction(AMI)[3-4].